I am a
Home I AM A Search Login

Papers of the Week


Papers: 5 Sep 2020 - 11 Sep 2020


Human Studies, Pharmacology/Drug Development

PAIN TYPE:
Migraine/Headache


2020 Sep 04


J Headache Pain


21


1

Improvements across a range of patient-reported domains with fremanezumab treatment: results from a patient survey study.

Authors

Buse DC, Gandhi SK, Cohen JM, Ramirez-Campos V, Cloud B, Yang R, Cowan RP
J Headache Pain. 2020 Sep 04; 21(1):109.
PMID: 32887548.

Abstract

The long-term safety and efficacy of fremanezumab were evaluated in a 52-week extension study (NCT02638103). Patient satisfaction with fremanezumab, dosing preferences, and patient-reported outcomes were assessed in a subpopulation who completed the extension study and consented to a follow-up questionnaire.